Navigation Links
Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
Date:6/13/2013

Nashua, NH (PRWEB) June 13, 2013

Eagle Biosciences is proud to announce the product launch of a brand new Calprotectin ELISA assay kit that offers the widest measurement range of any available assay (1-2000 µg/g stool). The Calprotectin ELISA assay kit is designed for quick and easy determination of human Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in stool samples. This launch further expands EagleBio’s gastrointestinal assay line which already includes Alpha 1 Antitrypsin ELISA, Anti-Gliadin IgG ELISA, Anti-Gliadin sIgA/IgA ELISA, Celiac EmA (Anti- Endomysium Antibody) IgG ELISA, Eosinophil Derived Neurotoxin (EDN) ELISA,Myeloperoxidase (MPO) Stool/Urine ELISA, Rotavirus Antigen ELISA, and Secretory IgA (sIgA) ELISA.

“This ELISA kit has excellent analytical sensitivity, as low as 1.8 µg/g, and results can be produced in about two hours with the added ease of incubations at room temperature,” said Dan Keefe, President of Eagle. “We are very excited about this product launch because calprotectin continues to gain enormous amounts of attention with regards to its significant role in gastrointestinal research and more specifically intestinal inflammation, especially now that the patent on measuring calprotectin in stool has expired and has opened the door for more players into the market.”

Keefe continued, “I have strong expectations that our Calprotectin ELISA assay kit will become an outstanding tool to researchers in the field. The product offers significant flexibility and efficiency as the kit can be used with most open automated assay systems. Looking forward, we will be complementing our ELISA product line with Calprotectin ELISA for serum/plasma in addition to other new kits in development that include NGAL ELISA for stool and MPO ELISA for stool.”

Eagle is offering promotional pricing for researchers measuring Calprotectin through the next few months. These assay kits are currently for research use only. Check out the Eagle website http://www.EagleBio.com or call 866-411-8023 for full details.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10815046.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... , March 22, 2017 The ... states a research report by Transparency Market Research (TMR). ... Amgen Inc., and AbbVie Inc., accounted for a share ... prominent players in this market are focusing aggressively on ... portfolio, which is likely to lead to market consolidation ...
(Date:3/22/2017)... 2017   Boston Biomedical , an industry leader ... target cancer stemness pathways, today announced its Board of ... Chief Executive Officer, effective April 24, 2017. ... , M.D., FACP, who has led Boston Biomedical since ... leadership, Boston Biomedical has grown from a "garage startup" ...
(Date:3/22/2017)... ... ... Okyanos Cell Therapy has announced Tallahassee, FL will be the next destination ... Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ first fully ... Act, Okyanos maintains a mission to help “no-option” patients and those with serious, ...
Breaking Biology Technology:
(Date:3/1/2017)... BEDFORD, Mass. , March 1, 2017  Aware, ... and services, announced that Richard P. Moberg ... Officer and co-President and Chief Financial Officer and Treasurer ... will continue to serve as a member of the ... T. Russell , Aware,s co-Chief Executive Officer and co-President, ...
(Date:2/28/2017)... 2017 News solutions for biometrics, bag drop ... ... 14 to 16 March, Materna will present its complete end-to-end ... travel is a real benefit for passengers. To accelerate the ... passenger touch point solutions to take passengers through the complete ...
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
Breaking Biology News(10 mins):